Oncology Pharma (ONPH) Stock Price, News & Analysis

Company Overview

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

Key Stats

• Today's Range: $0.05 to $0.07
• 50-Day Range: $0.05 to $0.11
• 52-Week Range: $0.00 to $0.36
• Volume: 20,172 shs
• Average Volume: 39,707 shs
• Market Capitalization: $2.17 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 6/15/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Computer Software
• Current Symbol: OTCMKTS:ONPH
• CIK: N/A
• Web: www.oncology-pharma.com
• Phone: (415) 869-1038
• Fax: 858-385-8997
• Employees: 1
• Year Founded: 1993

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 38,663,000
• Free Float: 31,704,000
• Market Cap: $2.17 million
• Optionable: Not Optionable
• Beta: -5.08